Transformative year ahead for Japan, according to CPhI report

A recent report from CPhI Japan has forecast that this year, 2018, will be a transformative year for Japanese pharma as the market is expected to see growth in generics, biosimilars and internationalisation. Read more

16 Jan 2018 11:01 Analysis